Sort
8,912 grants matching “sars cov 2”
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
$485,623Matthew Bryan Frieman · University Of Maryland Baltimore · R01 · FY2013 · AI
Enhancement of existing ABSL3 facilities to accommodate expanded mouse validation and phenotyping
$485,622Kc Kent Lloyd · University Of California At Davis · U42 · FY2021 · OD
Rapid olfactory tools for telemedicine-friendly COVID-19 screening and surveillance
$485,408Steven D Munger · University Of Florida · U01 · FY2021 · DC
PA-20-070: Evaluating home healthcare agency and home healthcare professional responsiveness to safety threats during older adults' care transitions in the era of COVID-19
$485,173Alicia Ines Arbaje · Johns Hopkins University · R01 · FY2021 · HS
Cilia-mediated mechanisms of viral entry into nasal mucosa
$484,989Chien-Ting Wu · Ut Southwestern Medical Center · R01 · FY2025 · AI
SARS-CoV Pathogenic Mechanisms in Senescent Mice
$484,651Ralph S Baric · Univ Of North Carolina Chapel Hill · R01 · FY2012 · AI
Project 4: Epigenetic modifiers of regulatory T cell function following viral pneumonia
$484,192Benjamin David Singer · Northwestern University At Chicago · P01 · FY2025 · HL
Ultrafast Biophysical Studies of Biomolecules at the NIH
$484,048Philip Anfinrud · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTA
$484,000Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2021 · CA
Systems investigation of vaccine responses in B cell depleted autoimmune patients
$483,750David A. Hafler · Yale University · U19 · FY2023 · AI
Convalescent Immune Plasma for the Treatment of COVID-19: Mechanisms Underlying the Host Immunologic and Virologic Response
$483,575Karen C Johnston · University Of Virginia · UL1 · FY2020 · TR
Expanding regional capacity for single molecule sequencing through the purchase of the Sequel IIe sequencing system
$483,512Melissa Laird Smith · University Of Louisville · S10 · FY2023 · OD
Pathogenesis of Jeilongvirus
$483,505Biao He · University Of Georgia · R01 · FY2017 · AI
Defining therapeutic drug targets for SARS-CoV-2-specific and pan-coronavirus inhibition
$483,500Charles M. Rice · Rockefeller University · R21 · FY2021 · AI
Understanding the OAS/RNase L pathway during pathogenic viral infections
$483,000James M Burke · University Of Florida · R35 · FY2023 · GM
Innate and adaptive defenses against SARS-COV-2 in the oral cavity during acute unvaccinated and breakthrough infections
$483,000Aaron Weinberg · Case Western Reserve University · R56 · FY2022 · DE
Understanding the OAS/RNase L pathway during pathogenic viral infections
$483,000James M Burke · University Of Florida · R35 · FY2025 · GM
Understanding the OAS/RNase L pathway during pathogenic viral infections
$483,000James M Burke · University Of Florida · R35 · FY2024 · GM
Mechanisms of immunopathology of COVID-19/ARDS, and strategies to mitigate detrimental inflammatory responses
$482,755Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Accelerating viral outbreak detection in US cities using mechanistic models, machine learning and diverse geospatial data
$482,268Alison P Galvani · Yale University · R01 · FY2021 · AI
Lipid and Protein Effects on Monolayer Stability
$482,170Joseph Anthony Zasadzinski · University Of Minnesota · R01 · FY2024 · HL
Development of therapeutics for SARS-CoV-2 infection
$482,150Hiroaki Mitsuya · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Impact of the COVID-19 pandemic, SARS-CoV-2 infection and social determinants of health on pregnancy complications, birth outcomes and post-pregnancy maternal cardiovascular and mortality outcomes
$481,842Angela M Malek · Medical University Of South Carolina · R01 · FY2024 · HL
Characterizing the ImPact of COVID-19 on Antibiotic PreScribing in AcutE Care and IDentifying Resilient Stewardship Strategies (POISED)
$481,666Michael Santino Pulia · University Of Wisconsin-Madison · R01 · FY2024 · HS
Optimization of Cu(II)-ligand catalysts, membrane materials, and coatings for O2-tolerant, portable, and low-cost electrochemical nitric oxide generation devices/catheters
$481,657Nicolai Lehnert · University Of Michigan At Ann Arbor · R01 · FY2024 · HL